Clinical Trials Directory

Explore 21,535 clinical trials worldwide

Showing 5801-5850 of 21,535 trials

Active filters:Status: Active, not recruiting

Clinical Trials (21,535)

NCT06252025
Immersive VR Reminiscence System for Facilitating Memory Retrieval Among Nursing Home Older Adults
NAActive, not recruiting
36 participants
Started: Jul 1, 2023 · Completed: Aug 1, 2024
3 conditions1 sponsor1 location
NCT05796427
"Testing SupporT for ADHD and Related Treatment (START) for Families of Children With ADHD"
NAActive, not recruiting
106 participants
Started: Jul 1, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05886712
Improving Access to Naloxone to Prevent Opioid Overdose Deaths (SAIA-Naloxone)
NAActive, not recruiting
31 participants
Started: Jul 1, 2023 · Completed: Jun 30, 2026
2 conditions3 sponsors1 location
NCT05925049
A Study Utilising Data From European Union (EU) National Multiple Sclerosis (MS) Registries to Assess the Incidence of Anti-Natalizumab Antibody Among Participants Who Receive Subcutaneous Administration of Natalizumab for Treatment of Relapsing-remitting Multiple Sclerosis (RRMS)
N/AActive, not recruiting
400 participants
Started: Jun 30, 2023 · Completed: Mar 31, 2026
1 condition1 sponsor1 location
NCT05915351
Enfortumab Vedotin in Previously Treated Locally Advanced or Metastatic Pancreatic Cancer (EPIC)
PHASE2Active, not recruiting
28 participants
Started: Jun 30, 2023 · Completed: Jun 1, 2026
3 conditions1 sponsor1 location
NCT05865496
A Study to Evaluate 611 in Patients With Chronic Rhinosinusitis With Nasal Polyps
PHASE2Active, not recruiting
90 participants
Started: Jun 30, 2023 · Completed: Jul 31, 2024
3 conditions1 sponsor4 locations
NCT05911763
A Study to Evaluate Impact of Efanesoctocog Alfa on Long-term Joint Health in Participants With Hemophilia A
N/AActive, not recruiting
200 participants
Started: Jun 30, 2023 · Completed: Sep 17, 2030
1 condition1 sponsor28 locations
NCT05736835
A Phase 2 Trial of the Immunogenicity and Safety of CVXGA Intranasal COVID Vaccine in Healthy Adults
PHASE2Active, not recruiting
227 participants
Started: Jun 30, 2023 · Completed: Jun 30, 2028
1 condition1 sponsor10 locations
NCT05906537
SKB410 for Injection in Solid Tumors
PHASE1Active, not recruiting
54 participants
Started: Jun 30, 2023 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT05921604
Baclofen Versus Gabapentin in Preventing Postoperative Pain After Laparoscopic Sleeve Gastrectomy
PHASE3Active, not recruiting
100 participants
Started: Jun 30, 2023 · Completed: Oct 31, 2025
1 condition1 sponsor1 location
NCT05898399
Study of ART6043 in Advanced/Metastatic Solid Tumors Patients
PHASE1/PHASE2Active, not recruiting
220 participants
Started: Jun 30, 2023 · Completed: Dec 14, 2026
2 conditions1 sponsor7 locations
NCT05939128
A Non-interventional Prospective Study of Early HER2-negative High-risk Breast Cancer and BRCA1/2 Mutations Prevalence in RussiA
N/AActive, not recruiting
625 participants
Started: Jun 30, 2023 · Completed: Sep 30, 2027
1 condition1 sponsor19 locations
NCT06113484
Impact of a Mediterranean Diet on Cardiovascular Disease Risk Factors
NAActive, not recruiting
90 participants
Started: Jun 30, 2023 · Completed: Dec 29, 2023
1 condition2 sponsors1 location
NCT05859035
Informational App Development for mHealth for Patient Self-Management of Opioid Use Disorder
NAActive, not recruiting
25 participants
Started: Jun 29, 2023 · Completed: Jan 10, 2024
1 condition3 sponsors1 location
NCT06011811
Cluster Headache Treatment Survey
N/AActive, not recruiting
5,000 participants
Started: Jun 29, 2023 · Completed: Jun 28, 2025
1 condition2 sponsors1 location
NCT05469789
A Study of Lanadelumab in Teenagers and Adults With Hereditary Angioedema (HAE)
N/AActive, not recruiting
50 participants
Started: Jun 29, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT06334081
Different Surgical Drilling Protocols in Posterior Maxilla
NAActive, not recruiting
16 participants
Started: Jun 29, 2023 · Completed: Jun 30, 2024
1 condition1 sponsor1 location
NCT05864846
A Study to Investigate Behavioral and Other Co-Occurring Outcomes With Epidiolex as Add-On Therapy in Participants Aged 1 to 65 Years of Age With Tuberous Sclerosis Complex
PHASE4Active, not recruiting
79 participants
Started: Jun 29, 2023 · Completed: Mar 26, 2026
1 condition1 sponsor19 locations
NCT05733611
RP2/RP3 in Combination With Atezolizumab and Bevacizumab for the Treatment of Patients With CRC
PHASE2Active, not recruiting
4 participants
Started: Jun 29, 2023 · Completed: Mar 1, 2027
3 conditions2 sponsors0 locations
NCT05741060
Effect of Equol Supplementation on Arterial Stiffness and Cognition in Healthy Volunteers
PHASE2Active, not recruiting
369 participants
Started: Jun 29, 2023 · Completed: Jan 30, 2027
3 conditions2 sponsors3 locations
NCT04716231
Atacicept in Subjects With IgA Nephropathy
PHASE3Active, not recruiting
376 participants
Started: Jun 29, 2023 · Completed: Jul 31, 2028
2 conditions1 sponsor1 location
NCT05531656
A Study to Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer's Disease
PHASE2Active, not recruiting
540 participants
Started: Jun 28, 2023 · Completed: Apr 30, 2027
1 condition3 sponsors50 locations
NCT05872386
"Bupe by the Book: A Tele-Buprenorphine Clinical Trial in Public Libraries With Unstably Housed Persons With Opioid Use Disorder"
NAActive, not recruiting
60 participants
Started: Jun 28, 2023 · Completed: Jun 30, 2025
2 conditions2 sponsors1 location
NCT05856448
A Study Evaluating the Effects of GLPG3667 Administered As Oral Treatment in Adult Participants with Active Systemic Lupus Erythematosus
PHASE2Active, not recruiting
186 participants
Started: Jun 28, 2023 · Completed: Mar 31, 2026
1 condition1 sponsor84 locations
NCT05783687
Real World Evidence Study in Subjects With Wilson's Disease
N/AActive, not recruiting
50 participants
Started: Jun 28, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor9 locations
NCT05768776
Outpatient Holmium LASER Enucleation of the Prostate: Benefit of MOSES(TM) 2.0 Technology
N/AActive, not recruiting
200 participants
Started: Jun 28, 2023 · Completed: Jul 31, 2025
2 conditions1 sponsor1 location
NCT05879978
A Study to Test How Well Different Doses of Obrixtamig (BI 764532) in Combination With Ezabenlimab Are Tolerated by People With Small Cell Lung Cancer and Other Neuroendocrine Tumours That Are Positive for DLL3
PHASE1/PHASE2Active, not recruiting
45 participants
Started: Jun 27, 2023 · Completed: Dec 26, 2025
2 conditions1 sponsor8 locations
NCT06001398
Parent Acceptance and Commitment Therapy (PACT) for Parents of Children With Pediatric Feeding Disorder
NAActive, not recruiting
73 participants
Started: Jun 27, 2023 · Completed: Dec 1, 2025
2 conditions2 sponsors1 location
NCT05898464
Immunogenicity and Safety of Recombinant Zoster Vaccine in People Living With HIV
PHASE4Active, not recruiting
150 participants
Started: Jun 27, 2023 · Completed: Mar 31, 2026
2 conditions3 sponsors2 locations
NCT06009861
Neoadjuvant Tislelizumab Plus Chemotherapy for Locally Advanced Oral/Oropharyngeal Cancer (NeoSPOT)
PHASE2Active, not recruiting
110 participants
Started: Jun 27, 2023 · Completed: Jun 30, 2027
2 conditions1 sponsor13 locations
NCT05696717
Phase 3 Efficacy and Durability of Ampreloxetine for the Treatment of Symptomatic nOH in Participants With Multiple System Atrophy
PHASE3Active, not recruiting
102 participants
Started: Jun 27, 2023 · Completed: Jan 31, 2028
2 conditions1 sponsor79 locations
NCT06083350
Effects of Yeast Beta-glucan on Cognitive Function in Patients With Mild Cognitive Impairment
NAActive, not recruiting
144 participants
Started: Jun 27, 2023 · Completed: Jun 30, 2025
2 conditions1 sponsor2 locations
NCT05500235
Comparing Smartphone to In-person Training to Scale Up a Tobacco Control Program for Teachers in India
NAActive, not recruiting
2,040 participants
Started: Jun 27, 2023 · Completed: Jul 31, 2025
1 condition2 sponsors1 location
NCT05634499
A Study of Giredestrant in Participants With Grade 1 Endometrial Cancer
PHASE2Active, not recruiting
30 participants
Started: Jun 27, 2023 · Completed: Jun 30, 2026
1 condition1 sponsor12 locations
NCT05836636
Immune Monitoring of Prevalent Kidney Transplant Recipients Using Torque Teno Virus: A Single-Center, Prospective Cohort Study
N/AActive, not recruiting
172 participants
Started: Jun 27, 2023 · Completed: Jul 31, 2025
3 conditions1 sponsor1 location
NCT05883644
Durvalumab and Tremelimumab as First Line Treatment in Participants With Advanced Hepatocellular Carcinoma (HCC)
PHASE3Active, not recruiting
111 participants
Started: Jun 27, 2023 · Completed: Mar 31, 2026
1 condition1 sponsor40 locations
NCT05601752
ADP-A2M4CD8 Monotherapy and in Combination with Nivolumab in HLA-A2+ Subjects with MAGE-A4 Positive Ovarian Cancer (SURPASS-3)
PHASE2Active, not recruiting
66 participants
Started: Jun 26, 2023 · Completed: Aug 12, 2026
1 condition2 sponsors23 locations
NCT05627063
A Study to Assess Safety, Tolerability, and Pharmacokinetics of ABSK121-NX in Patients With Advanced Solid Tumors
PHASE1Active, not recruiting
169 participants
Started: Jun 26, 2023 · Completed: Jun 30, 2026
1 condition1 sponsor24 locations
NCT05966480
Phase 2 Placebo-Controlled Study to Assess the Safety and Efficacy of ESK-001 in Active Systemic Lupus Erythematosus
PHASE2Active, not recruiting
408 participants
Started: Jun 26, 2023 · Completed: Sep 1, 2027
1 condition1 sponsor169 locations
NCT05756972
A Study of PM8002 (Anti-PD-L1/VEGF) in Combination With Chemotherapy in Patients With NSCLC
PHASE2Active, not recruiting
64 participants
Started: Jun 26, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05880849
Choline Effects - Pre-symptomatic AD
PHASE1Active, not recruiting
14 participants
Started: Jun 26, 2023 · Completed: Nov 30, 2026
1 condition4 sponsors1 location
NCT05735730
Can the Risk for AMD be Modulated?
NAActive, not recruiting
1,800 participants
Started: Jun 26, 2023 · Completed: Jan 12, 2028
1 condition1 sponsor1 location
NCT05983562
Examining the Feasibility of Prolonged Ketone Concentrate Supplement Drink Consumption in Adults With Type 2 Diabetes
NAActive, not recruiting
20 participants
Started: Jun 26, 2023 · Completed: Mar 31, 2024
3 conditions1 sponsor1 location
NCT06339866
The Effect of Two Different Video Showings on Pain and Anxiety in Children Undergoing Adenotonsillectomy
NAActive, not recruiting
120 participants
Started: Jun 25, 2023 · Completed: Jun 25, 2024
1 condition1 sponsor1 location
NCT06244251
Comparison Between Laparoendoscopic Single-site Surgery and Multi-port Laparoscopy in Treating Uterine Fibroids
NAActive, not recruiting
5,000 participants
Started: Jun 24, 2023 · Completed: Dec 31, 2026
3 conditions1 sponsor1 location
NCT06621784
Core Stabilization Exercises in Patients with Knee Osteoarthritis
NAActive, not recruiting
32 participants
Started: Jun 23, 2023 · Completed: Oct 9, 2024
5 conditions1 sponsor1 location
NCT05721729
Effect of Mizagliflozin Repeat Dosing on Adverse Events and Postprandial Glucose Excursions
PHASE2Active, not recruiting
15 participants
Started: Jun 23, 2023 · Completed: May 1, 2025
1 condition1 sponsor2 locations
NCT06096025
Short Versus Long Duration of Therapy for Streptococcus Pneumoniae Bloodstream Infections
N/AActive, not recruiting
200 participants
Started: Jun 23, 2023 · Completed: Jun 23, 2026
1 condition1 sponsor1 location
NCT05845814
A Study of Efficacy and Safety of Pembrolizumab Plus Enfortumab Vedotin (EV) +/- Investigational Agents in First-Line Metastatic Urothelial Carcinoma (mUC) (MK-3475-04B/KEYMAKER-U04)
PHASE1/PHASE2Active, not recruiting
390 participants
Started: Jun 23, 2023 · Completed: May 31, 2027
2 conditions1 sponsor47 locations
NCT05877547
A Clinical Study of Efinopegdutide in Participants With Precirrhotic Nonalcoholic Steatohepatitis (NASH) (MK-6024-013)
PHASE2Active, not recruiting
360 participants
Started: Jun 23, 2023 · Completed: Dec 29, 2025
5 conditions1 sponsor175 locations